Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 138

Results For "INST"

3147 News Found

Health Minister Mandaviya delivers keynote address 2nd Voice of Global South Summit 2023
Policy | November 20, 2023

Health Minister Mandaviya delivers keynote address 2nd Voice of Global South Summit 2023

Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure


Alkem healthy lungs initiative to promote importance of inhalation therapy
Healthcare | November 17, 2023

Alkem healthy lungs initiative to promote importance of inhalation therapy

The countrywide initiative aims to spread awareness, educate the public & ensure that no one is left behind in the fight against respiratory diseases


Dr. Reddy's rolls out drug-free non-invasive migraine management device ‘Nerivio’ in India
News | November 17, 2023

Dr. Reddy's rolls out drug-free non-invasive migraine management device ‘Nerivio’ in India

Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain


Pfizer and Astellas' XTANDI approved by USFDA in earlier prostate cancer treatment setting
Drug Approval | November 17, 2023

Pfizer and Astellas' XTANDI approved by USFDA in earlier prostate cancer treatment setting

XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer


IOL Chemicals and Pharmaceuticals Q2 PAT jumps 141% to Rs. 37.8 Cr
News | November 15, 2023

IOL Chemicals and Pharmaceuticals Q2 PAT jumps 141% to Rs. 37.8 Cr

EBITDA for Q2 FY24 at Rs. 71.2 crore as compared to Rs. 79.9 crore QoQ


Kesin Pharma announces FDA approval and availability of Likmez oral suspension
Drug Approval | November 15, 2023

Kesin Pharma announces FDA approval and availability of Likmez oral suspension

Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing


Wockhardt Q2 FY24 consolidated loss lowers at Rs. 77 Cr
News | November 15, 2023

Wockhardt Q2 FY24 consolidated loss lowers at Rs. 77 Cr

Wockhardt has reported total income of Rs. 777 crores during the period ended September 30, 2023


Natco Pharma posts consolidated Q2F Y24 PAT of Rs. 369 Cr
News | November 15, 2023

Natco Pharma posts consolidated Q2F Y24 PAT of Rs. 369 Cr

Natco Pharma has reported total income of Rs. 1060.8 crores during the period ended September 30, 2023


Solara Active Pharma Sciences posts consolidated Q2 FY2024 loss at Rs. 17.16 Cr
News | November 15, 2023

Solara Active Pharma Sciences posts consolidated Q2 FY2024 loss at Rs. 17.16 Cr

Solara Active Pharma Sciences has reported total income of Rs. 426.42 crores during the period ended September 30, 2023


Narayana Hrudayalaya Q2 FY PAT up at Rs. 226.58 Cr
News | November 14, 2023

Narayana Hrudayalaya Q2 FY PAT up at Rs. 226.58 Cr

Narayana Hrudayalaya has reported total income of Rs. 1323.64 crores during the period ended September 30, 2023